Chickasaw Capital Management’s Walgreens Boots Alliance WBA Stock Holding History

Chickasaw Capital Management’s Portfolio WBA Stock Details WBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,027	Closed	-$290K	–	94
2023 Q3	$290K	Hold	13,027	–	–	0.02%	73
2023 Q2	$371K	Sell	13,027 -1,525	-10%	-$49.7K	0.02%	68
2023 Q1	$503K	Hold	14,552	–	–	0.03%	62
2022 Q4	$544K	Sell	14,552 -1,972	-12%	-$74.1K	0.03%	61
2022 Q3	$519K	Hold	16,524	–	–	0.03%	58
2022 Q2	$626K	Sell	16,524 -450	-3%	-$19.3K	0.03%	59
2022 Q1	$760K	Sell	16,974 -530	-3%	-$26.1K	0.03%	57
2021 Q4	$913K	Sell	17,504 -1,200	-6%	-$58.1K	0.05%	57
2021 Q3	$880K	Hold	18,704	–	–	0.04%	54
2021 Q2	$984K	Buy	18,704 +2,070	+12%	+$111K	0.04%	53
2021 Q1	$913K	Buy	16,634 +100	+0.6%	+$4.94K	0.05%	53
2020 Q4	$659K	Sell	16,534 -2,075	-11%	-$80.4K	0.04%	54
2020 Q3	$668K	Buy	18,609 +110	+0.6%	+$4.3K	0.05%	52
2020 Q2	$784K	Sell	18,499 -5,740	-24%	-$244K	0.04%	47
2020 Q1	$1.11M	Sell	24,239 -1,578	-6%	-$80.1K	0.08%	47
2019 Q4	$1.52M	Sell	25,817 -586	-2%	-$33.8K	0.04%	49
2019 Q3	$1.46M	Sell	26,403 -19	-0.1%	-$1.02K	0.04%	47
2019 Q2	$1.44M	Sell	26,422 -200	-0.8%	-$10.6K	0.04%	45
2019 Q1	$1.68M	Buy	26,622 +775	+3%	+$52.9K	0.04%	45
2018 Q4	$1.77M	Sell	25,847 -700	-3%	-$54.3K	0.05%	49
2018 Q3	$1.94M	Sell	26,547 -915	-3%	-$62.1K	0.04%	52
2018 Q2	$1.65M	Sell	27,462 -60	-0.2%	-$3.86K	0.03%	56
2018 Q1	$1.8M	Buy	27,522 +1,792	+7%	+$128K	0.04%	54
2017 Q4	$1.87M	Buy	25,730 +7,585	+42%	+$534K	0.04%	55
2017 Q3	$1.4M	Hold	18,145	–	–	0.03%	55
2017 Q2	$1.42M	Buy	18,145 +800	+5%	+$65.8K	0.03%	56
2017 Q1	$1.44M	Buy	17,345 +10,945	+171%	+$918K	0.03%	54
2016 Q4	$530K	Buy	6,400 +600	+10%	+$49.6K	0.01%	68
2016 Q3	$468K	Hold	5,800	–	–	0.01%	66
2016 Q2	$483K	Hold	5,800	–	–	0.01%	68
2016 Q1	$489K	Sell	5,800 -250	-4%	-$20K	0.02%	68
2015 Q4	$515K	Hold	6,050	–	–	0.02%	70
2015 Q3	$503K	Sell	6,050 -210	-3%	-$19K	0.02%	71
2015 Q2	$529K	Sell	6,260 -925	-13%	-$79.7K	0.02%	76
2015 Q1	$608K	Hold	7,185	–	–	0.02%	75
2014 Q4	$547K	Hold	7,185	–	–	0.02%	78
2014 Q3	$426K	Hold	7,185	–	–	0.01%	80
2014 Q2	$533K	Hold	7,185	–	–	0.02%	75
2014 Q1	$474K	Hold	7,185	–	–	0.02%	77
2013 Q4	$413K	Hold	7,185	–	–	0.02%	81
2013 Q3	$386K	Sell	7,185 -97,930	-93%	-$4.92M	0.03%	80
2013 Q2	$4.65M	Buy	+105,115	New	+$5.12M	0.35%	28

Other funds holding WBA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Chickasaw Capital Management's WBA Position: Q4 2023 in Review

Chickasaw Capital Management sold out of Walgreens Boots Alliance (WBA) in Q4 2023, closing a stake of 13,027 shares — an estimated $290K sold.

Chickasaw Capital Management first reported a position in WBA in Q2 2013 and held it in 42 quarters. The position peaked at $4.65M in Q2 2013. 1,071 funds tracked by Wall St. Rank hold WBA as of Q4 2023.

Chickasaw Capital Management reported no remaining Walgreens Boots Alliance position as of Q4 2023 after selling out during the quarter.
Chickasaw Capital Management sold 13,027 Walgreens Boots Alliance shares in Q4 2023, an estimated $290K.
Chickasaw Capital Management first reported a position in Walgreens Boots Alliance in Q2 2013 and held it in 42 quarters.
Chickasaw Capital Management's Walgreens Boots Alliance position peaked at $4.65M in Q2 2013.
1,071 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2023.

Based on Chickasaw Capital Management's 13F filing for Q4 2023, filed 12 Jan 2024.